PULMICORT 0.25mg/ml Price

Overview

Welcome to Dwaey, specifically on PULMICORT 0.25mg/ml Nebulization/Suspension for page.
This medicine contains an important and useful components, as it consists of Budesonide.
PULMICORT 0.25mg/ml is available in the market in concentration 0.25mg/ml and in the form of Nebulization/Suspension for.

ASTRAZENECA AB is the producer of PULMICORT 0.25mg/ml and it is imported from SWEDEN, The most popular alternatives of PULMICORT 0.25mg/ml are listed downward .

Mode Of Action

Budesonide controls the rate of protein synthesis, depresses the migration of polymorphonuclear leukocytes, fibroblasts, reverses capillary permeability and lysosomal stabilisation at the cellular level to prevent or control inflammation.

Indication

• Asthma
• COPD.

Precaution

Active or doubtfully quiescent tuberculosis, paradoxical bronchospasm; untreated fungal, bacterial, or systemic viral infections, or ocular herpes simplex infection. Lactation: Drug enters breast milk; use only if benefits greatly outweigh risks

Side Effects

• >10% Respiratory infection (34-38%)
• Rhinitis (7-12%)
• Otitis media (1-12%) 1-10% Nasopharyngitis (10%)
• Nasal congestion (3%)
• Pharyngitis (3%)
• Allergic rhinitis (2%)
• Viral gastroenteritis (2%)
• Viral upper respiratory tract infection (2%)
• Oral candidiasis (1%)

Contra indication

Hypersensitivity to any of the ingredients of this preparation.

Pregnancy and lactation

Pregnancy category: B

Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.